Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes.
Wu X, Chen N, Hsu P, Sun J, Li W, Wang Q, Samira M, Wei Q, Yu J, Cao G, Yang H, Wang L, Wang J, Jin Y, Liu W, Wu J, He J, Lyu C, Zhang J.
Wu X, et al. Among authors: wang l, wang j, wang q.
Clin Transl Sci. 2024 Jul;17(7):e13877. doi: 10.1111/cts.13877.
Clin Transl Sci. 2024.
PMID: 39014868
Free PMC article.
Clinical Trial.